Galecto Biotech
A Swedish company founded in 2011 by leading galectin scientists and biotech executives from Sweden, United Kingdom, and Denmark.
Galecto Biotech has raised €79M across 1 funding round from 9 investors, most recently a Series C round in Oct 2018. Based in Copenhagen, Denmark; founded 2011; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€79M
€79,000,000
Funding rounds
1
Investors
9
distinct backers
Active since
2018-10
latest 2018-10
Funding by year
EUR raised per yearGalecto Biotech — funding by year — interactive chart.
Data table
| Galecto Biotech — funding by year | |
|---|---|
| 2018 | €79M |
Signals
High confidenceRaise-next likelihood9
base rate 50% for Series C
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2018-10-01 | Series C | €79M | Bristol Myers Squibb,HBM Healthcare Investments,M Ventures,Maverick Ventures,Novo Seeds,OrbiMed+3 more | View deal → |
Investors
9Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Oura Health€779MFinland · Healthtech
Global coverage: FundingData